Il Levetiracetam nel trattamento delle crisi parziali in pazienti resistenti al Topiramato

Translated title of the contribution: Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients

S. D'Arcangelo, A. M. Bacchetta, G. Egeo, A. T. Giallonardo, F. Randi, N. Vanacore, M. R. De Feo

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.

Translated title of the contributionLevetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients
Original languageItalian
Pages (from-to)183-185
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number121-122
Publication statusPublished - Jul 2003

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients'. Together they form a unique fingerprint.

Cite this